Amyris Inc (NASDAQ: AMRS)
Amyris has been an incredibly interesting stock to watch as of late. Lately, there has been several bits of positive news released with regard to the company. Today, the positive news continues to flood the internet, as yet another contract has been signed that will lead to stronger revenue for the company. Today, we’ll talk about the contract news that was recently released, other recent positive news surrounding the stock, and what we can expect to see from AMRS moving forward.
Trade smarter and make more money with Tradespoon!
AMRS Enters Agreement With The U.S. Department Of Energy
As mentioned above, we received yet another great piece of news surrounding Amyris recently. It was announced that the company has been awarded a new United States Department of Energy contract. The contract surrounds the manufacturing of cellulose-derived farnesene for biofuels.
Under the agreement, AMRS will team up with Renmatix and Total New Energies USA. The three companies will work together in order to develop a manufacturing-ready process using wood as the cellulosic feedstock to produce farnesene. Farnesene is a hydrocarbon building block used to manufacture a wide range of products. These products include cosmetics, detergents, base oils, lubricants, and diesel and jet fuel.
According to the announcement, the agreement has a term of three years. In return for their involvement, AMRS will receive payments adding up to millions of dollars. In a recent statement, John Melo, President and CEO at Amyris, had the following to offer:
“We’re pleased to parnter with Renmatix and Total in furthering the advancement of cellulose-derived farnesene… Success in this project could enable farnesene cost below $1 a liter, which will deliver breakthrough results in a variety of products, including biofuels, while at the same time leveraging the existing large forestry infrastructure to utilize renewable wood sources and wood waste as a sugar source to produce it.”
Other Reasons To Be Bullish
While the news that AMRS won the U.S. Department of Energy contract is great news, this is only one piece of good news that we’ve seen very recently surrounding the company. In fact, the company has won several contracts at this point. In fact, just over the past month and a half, we learned of these two other collaboration agreements:
- Biogen – Just weeks ago, we learned that AMRS entered into a collaboration agreement with leading pharmaceutical company, Biogen. The goal of the partnership between the two company’s is to look into the use of advanced microbe engineering technology to evaluate and develop mutiple host microorganisms as alternatives to mammalian cell lines for the product of therapeutic recombinant proteins. To learn more about this partnership, click here.
- Givaudan – Another big piece of news came about a month and a half ago, when Amyris announced that it would be teaming up with Givaudan. Givaudan is a global leader in flavors and fragrances. With Givaudan, AMRS will work to develop proprietary fragrance ingredients. To learn more about this agreement, click here.
What I’m Expecting To See Moving Forward
Moving forward, I have an overwhelmingly bullish opinion of what we can expect to see from AMRS. The positive news that we’ve seen surrounding the stock recently will help to boost revenue, leading to strong growth. As a result, I’m expecting to see gains in the stock moving forward.
Don’t waste your time! Click here to find winning trades in minutes!
What Do You Think?
Where do you think AMRS is headed? Join the discussion at TalkTRENDZ!